imatinib mesylate has been researched along with Malaria, Falciparum in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, ME; Nelson, SW; Parrott, EE; Singh, R | 1 |
| Cooper, RA; Kirkman, L | 1 |
| Chien, HD; Kesely, KR; Low, PS; Noomuna, P; Pantaleo, A; Putt, KS; Tuan, TA; Turrini, FM | 1 |
1 trial(s) available for imatinib mesylate and Malaria, Falciparum
| Article | Year |
|---|---|
Imatinib augments standard malaria combination therapy without added toxicity.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Drug Therapy, Combination; Fever; Humans; Imatinib Mesylate; Malaria, Falciparum; Middle Aged; Quinolines; Treatment Outcome; Vietnam; Young Adult | 2021 |
2 other study(ies) available for imatinib mesylate and Malaria, Falciparum
| Article | Year |
|---|---|
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
Topics: Antimalarials; Apicoplasts; Chloroplasts; DNA; DNA-Directed DNA Polymerase; Drug Discovery; Exonucleases; Humans; Kinetics; Malaria, Falciparum; Mitochondria; Multienzyme Complexes; Nucleic Acid Synthesis Inhibitors; Peptide Library; Plasmodium falciparum; Protozoan Proteins; Spectrometry, Fluorescence | 2014 |
Can repurposing drugs play a role in malaria control?
Topics: Antimalarials; Artemisinins; Drug Repositioning; Drug Resistance, Microbial; Female; Humans; Imatinib Mesylate; Malaria; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic | 2021 |